Hartford Investment Management Co. Sells 106 Shares of Humana Inc. $HUM

Hartford Investment Management Co. decreased its position in shares of Humana Inc. (NYSE:HUM) by 1.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,254 shares of the insurance provider’s stock after selling 106 shares during the period. Hartford Investment Management Co.’s holdings in Humana were worth $1,773,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in the company. Vanguard Group Inc. boosted its position in Humana by 8.9% in the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider’s stock valued at $3,697,222,000 after buying an additional 1,143,662 shares in the last quarter. Dodge & Cox raised its stake in shares of Humana by 5.5% during the first quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider’s stock valued at $2,845,830,000 after acquiring an additional 557,175 shares during the last quarter. Pzena Investment Management LLC raised its stake in Humana by 6.1% during the first quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider’s stock worth $1,013,133,000 after buying an additional 219,541 shares during the last quarter. Davis Selected Advisers raised its stake in Humana by 3.3% during the first quarter. Davis Selected Advisers now owns 2,331,343 shares of the insurance provider’s stock worth $616,873,000 after buying an additional 74,434 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC increased its stake in Humana by 1.6% in the first quarter. Hotchkis & Wiley Capital Management LLC now owns 1,236,936 shares of the insurance provider’s stock valued at $327,293,000 after purchasing an additional 19,613 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on HUM. Royal Bank Of Canada lifted their price target on shares of Humana from $283.00 to $322.00 and gave the company an “outperform” rating in a research note on Thursday, August 21st. Bank of America lifted their price target on shares of Humana from $285.00 to $312.00 and gave the company a “neutral” rating in a research note on Tuesday, September 2nd. Truist Financial decreased their price target on shares of Humana from $280.00 to $260.00 and set a “hold” rating for the company in a research note on Wednesday, July 16th. Morgan Stanley decreased their price target on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a research note on Thursday, July 31st. Finally, Piper Sandler decreased their target price on shares of Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a research report on Thursday, July 31st. Seven research analysts have rated the stock with a Buy rating and seventeen have issued a Hold rating to the stock. According to MarketBeat.com, Humana has a consensus rating of “Hold” and an average price target of $289.50.

Humana Trading Up 0.1%

NYSE:HUM opened at $254.72 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The firm has a 50-day moving average of $271.91 and a 200-day moving average of $257.37. The company has a market cap of $30.64 billion, a PE ratio of 19.55, a PEG ratio of 1.50 and a beta of 0.44. Humana Inc. has a one year low of $206.87 and a one year high of $324.38.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing the consensus estimate of $6.32 by ($0.05). The business had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company’s revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the firm earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, equities research analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a yield of 1.4%. Humana’s payout ratio is 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.